Table 1. Correlation of chemotherapeutic response and clinicopathologic features with Apollon expression.
| expression of Apollon | P values | OR (95%CI) | ||
|---|---|---|---|---|
| Negative | Positive | |||
| Patients | 26 | 44 | ||
| Age, years | ||||
| ≤56 | 8 | 14 | ||
| >56 | 18 | 30 | 0.927 | 0.952 (0.334-2.713) |
| Lymph nodes metastasis | ||||
| No | 11 | 21 | ||
| Yes | 15 | 23 | 0.660 | 0.803 (0.302-2.134) |
| Distant metastasis | ||||
| No | 6 | 9 | ||
| Yes | 20 | 35 | 0.796 | 1.167 (0.362-3.759) |
| Invasive depth | ||||
| Mucosa to muscularisproria | 10 | 14 | ||
| Adventitia to adjacent structure | 16 | 30 | 0.572 | 1.339 (0.486-3.689) |
| Tumor size (cm) | ||||
| ≤ 4 | 12 | 15 | ||
| > 4 | 14 | 29 | 0.318 | 1.657 (0.615-4.466) |
| Position | ||||
| Upper and middle | 21 | 37 | ||
| Hypomere | 5 | 7 | 0.722 | 0.795 (0.224-2.819) |
| TNM stage | ||||
| I, II | 15 | 17 | ||
| III, IV | 11 | 27 | 0.125 | 2.166 (0.807-5.809) |
| Tumor differentiation | ||||
| I, II | 18 | 27 | ||
| III | 8 | 17 | 0.508 | 1.417 (0.506-3.970) |
| Chemosensitivity | ||||
| CR + PR | 16 | 9 | ||
| SD + PD | 10 | 35 | 0.001 | 6.222 (2.119-18.275) |
Bold P value less than 0.05 indicates statistical significance.